Evidence map›Paper›PMID 39650078›Full record

ArticleIranian journal of otorhinolaryngology2024

Transoral Laser Microsurgery of Supraglottic Cancer: A Survival Analysis.

Samaneh Abdi Sofi, Payman Dabirmoghaddam, Kayvan Aghazadeh, Ebrahim Karimi, Shadi Naderyan Fe'li

Abstract read
In one paragraph

Article in Iranian journal of otorhinolaryngology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samaneh Abdi SofiAmir A'lam Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Payman DabirmoghaddamOtorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Kayvan AghazadehOtorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ebrahim KarimiOtorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Shadi Naderyan Fe'liDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: There needs to be more unanimity in the treatment approaches for supraglottic squamous cell carcinoma. This study evaluated the survival outcomes of patients who underwent transoral laser microsurgery for this type of cancer. Materials and Methods: This longitudinal study was conducted at a tertiary university hospital in Iran. Forty-one patients with supraglottic squamous cell carcinoma who underwent transoral laser microsurgery were included. The required data were extracted from medical records. Survival analysis using the Kaplan-Meier method was used to obtain the 5-year overall recurrence-free and laryngectomy-free survival rates. Results: This study included 40 males (97.6%) and one female (2.4%). The mean ± standard deviation of patients' age was 55.17±8.43 years. The 5-year overall recurrence-free survival rate in all patients was 68.0%. In contrast, 76.0% of the cases were laryngectomy-free after five years. Patients in the T1 and T3 categories had better overall and laryngectomy-free survival rates when stratifying by disease stage, respectively. The 3-year local control rates of tumor were 80.0%, 63.1%, and 82.3% for T1, T2, and T3, respectively. The larynx could be preserved in four patients (80.0%) with T1, 15 patients (57.8%) with T2, and 14 patients (82.3%) with T3. Conclusion: Our results suggest that transoral laser microsurgery may result in satisfactory recurrence-free survival and good oncologic outcomes. However, considering the indication of radiotherapy in some patients, the therapeutic effects of radiotherapy are part of the survival rate observed in this study.

Indexed as

CarcinomaLarynxMicrosurgerySurvival

Identifiers

PMID39650078
PMCPMC11624849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.